Academic Journal

Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017.

التفاصيل البيبلوغرافية
العنوان: Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017.
المؤلفون: Doshi, Peter, Spence, O'Mareen, Kuzucan, Aida, Powers III, John H., Powers, John H 3rd
المصدر: JAMA Internal Medicine; May2019, Vol. 179 Issue 5, p719-721, 3p
قاعدة البيانات: Complementary Index
الوصف
تدمد:21686106
DOI:10.1001/jamainternmed.2018.7040